InvestorsHub Logo
Followers 58
Posts 10217
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 147796

Tuesday, 04/17/2018 9:32:07 AM

Tuesday, April 17, 2018 9:32:07 AM

Post# of 465528
Xena...your assessment on this from todays PR ?

In addition, an updated investigational new drug application (IND) for the double-blind, randomized, placebo-controlled ANAVEX®2-73 Phase 2 study in Rett syndrome was submitted to the FDA in the first quarter of 2018. The Company is currently in dialogue with the agency and anticipates potential initiation of this clinical trial H2 2018. Additional protocol details will be shared at that point.



After multiple direct attempts to get facts this kind of response is not acceptable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News